tiprankstipranks
Galderma Group AG (CH:GALD)
:GALD
Switzerland Market
GALD
Galderma Group AG
RESEARCH TOOLSreports

Galderma Group AG (GALD) Stock News & Sentiment

13 Followers
Capitalizing on Emerging Aesthetic Demand: Galderma’s Menopause and GLP‑1 Weight Loss Opportunity Supports Reiterated Buy Rating
Premium
Ratings
Capitalizing on Emerging Aesthetic Demand: Galderma’s Menopause and GLP‑1 Weight Loss Opportunity Supports Reiterated Buy Rating
3d ago
Galderma Group AG: Buy Rating on Resilient Demand, Growth Catalysts, and Undervalued Long-Term Cash Generation
Premium
Ratings
Galderma Group AG: Buy Rating on Resilient Demand, Growth Catalysts, and Undervalued Long-Term Cash Generation
5d ago
Sustained Growth and Favorable Risk‑Reward in Injectable Aesthetics Underpin Galderma Buy Rating
Premium
Ratings
Sustained Growth and Favorable Risk‑Reward in Injectable Aesthetics Underpin Galderma Buy Rating
15d ago
Galderma: Restylane Contour Label Expansion Strengthens Aesthetics Leadership and Supports Buy Rating
Premium
Ratings
Galderma: Restylane Contour Label Expansion Strengthens Aesthetics Leadership and Supports Buy Rating
20d ago
Hold Rating Maintained as Supportive FY26 Guidance Offers Limited Upside Versus High Expectations and Valuation
Premium
Ratings
Hold Rating Maintained as Supportive FY26 Guidance Offers Limited Upside Versus High Expectations and Valuation
1M ago
Buy Rating Backed by Strong Q4 Performance, Upgraded Nemluvio Outlook, and Enhanced 2026 Guidance Upside
Premium
Ratings
Buy Rating Backed by Strong Q4 Performance, Upgraded Nemluvio Outlook, and Enhanced 2026 Guidance Upside
1M ago
Buy Rating on Galderma: Leading Global Skin‑Health Platform with Diversified Growth and Undervalued Upside
Premium
Ratings
Buy Rating on Galderma: Leading Global Skin‑Health Platform with Diversified Growth and Undervalued Upside
1M ago
More CH:GALD News >

GALD News on the Web

Barclays Keeps Their Buy Rating on Galderma Group AG (GALD)
TipRanks News
Bullish
Capitalizing on Emerging Aesthetic Demand: Galderma’s Menopause and GLP‑1 Weight Loss Opportunity Supports Reiterated Buy Rating
TipRanks News
Bullish
Galderma Group AG (GALD) Gets a Buy from Barclays
TipRanks News
Bullish
Jefferies Reaffirms Their Buy Rating on Galderma Group AG (GALD)
TipRanks News
Bullish
Galderma Group AG: Buy Rating on Resilient Demand, Growth Catalysts, and Undervalued Long-Term Cash Generation
TipRanks News
Bullish
Galderma Group AG (GALD) Receives a Buy from Berenberg Bank
TipRanks News
Bullish
H.C. Wainwright Sticks to Their Buy Rating for Galderma Group AG (GALD)
TipRanks News
Bullish
Galderma Group AG (GALD) Gets a Buy from Barclays
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
CH:GALD
Sector Average
Media Buzz
This Week4 articles
Weekly Average2.75 articles
News Sentiment
This Week100%
Sector Average69%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CH:GALD’s Media Buzz Sentiment?
4 articles about CH:GALD were published this week. In an average week, 2.75 articles are published.
    What is CH:GALD’s weekly average amount of articles?
    In an average week, 2.75 articles about CH:GALD are published.
      What is CH:GALD’s News Sentiment?
      100% of articles about CH:GALD were positive this week, compared to its sector average of 69%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        STAAStaar Surgical
        IVVDInvivyd
        SLPSimulations Plus
        REPLReplimune Group
        Showing the stocks with the most bullish news sentiment over the past week